Cost-Effectiveness Analysis of Bevacizumab in Combination with PC Regimen Versus PC Regimen in Non-Small Cell Lung Cancer Treatment
May 1, 2014, 00:00
10.1016/j.jval.2014.03.506
https://www.valueinhealthjournal.com/article/S1098-3015(14)00557-9/fulltext
Title :
Cost-Effectiveness Analysis of Bevacizumab in Combination with PC Regimen Versus PC Regimen in Non-Small Cell Lung Cancer Treatment
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00557-9&doi=10.1016/j.jval.2014.03.506
First page :
A87
Section Title :
Cancer
Open access? :
No
Section Order :
1555